HEALTHEQUITY, INC.
About HEALTHEQUITY, INC.
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2026
- $1.3B
- Net income
- $215.2M
- Total assets
- $3.4B
- Market cap
- $7.4B
- Gross margin
- 64.8%
- Operating margin
- 13.5%
- Net margin
- 8.1%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $1.2B
- Cost of revenue
- $422.5M
- Gross profit
- $777.3M
- Operating expenses
- $614.9M
- Operating income
- $162.3M
- Income tax
- $19.3M
- Net income
- $96.7M
- EPS (basic)
- $1.11
- EPS (diluted)
- $1.09
Balance sheet
- Total assets
- $3.4B
- Current assets
- $477.7M
- Total liabilities
- $1.3B
- Current liabilities
- $156.3M
- Shareholders’ equity
- $2.1B
Cash flow
- Operating cash flow
- $339.9M
- Investing cash flow
- -$505.5M
- Financing cash flow
- $57.6M
- Net cash flow
- -$108.0M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $7.4B
- P/E ratio
- 82.3
- EPS (diluted)
- $1.09
- Shares outstanding
- 82.6M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jul 31, 2014
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Profitable — net income of $215.2M in FY2026.
- Revenue grew 64% from FY2021 to FY2025.
- Gross margin of 64.8%, net margin 8.1%.
- Trading 21% below its 52-week high.
- Valued at a price-to-earnings (P/E) ratio of 82.3.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
Peers & competitors
No reviews yet. Be the first to review HEALTHEQUITY, INC..
Write a review
News about HEALTHEQUITY, INC.
News & sentiment via Polygon.io
